Fast Five Quiz: Low-Risk Myelodysplastic Syndrome Reviewed by Maurie Markman, MD; Rami Komrokji, MD

https://reference.medscape.com/viewarticle/myelodysplastic-syndrome-low-risk-2025a1000d2m?_gl=1*1gr9w5e*_gcl_au*NjkzMDY5MjIxLjE3ODA2NzA2MDAuMTAxODc1NTU5LjE3ODM4NjY0NjYuMTc4Mzg2NjQ2Ng.. Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematopoietic stem cell disorders, each associated with varying levels of prognosis. Risk stratification is an important component of MDS; however, even lower-risk variants require a nuanced approach to management, and certain factors can further affect patient risk after diagnosis.